Skip to content

Effects of cold water immersion after crossfit® practitioners: randomized, blind, controlled clinical trial

Effects of cold water immersion on recovery of indirect markers of muscle damage in crossfit® practitioners: randomized, blind, controlled clinical trial - CT: The expansion of the acronym CT is Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-6nw7p8
Enrollment
Unknown
Registered
2020-07-09
Start date
2019-11-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myalgia, Muscle Fatigue

Interventions

All volunteers will performe a sequence of exercise which will be divided into four groups (8 participant in each group). High volume with cold water immersion, Low volume with cold water immersion, H
Other
N03.706.615.049

Sponsors

Universidade Federal do Rio Grande do Norte
Lead Sponsor
Universidade Federal do Rio Grande do Norte
Collaborator

Eligibility

Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Men and women, CrossFit® practioners; age between 18 and 40 years old; at least 6 years of regular physical practice; practice CrossFit® at least 3 times a week; have performed at least twelve WOD's the last 4 weeks; have experience in Karen WOD; do not have performed a Karen WOD the last 4 weeks; have participated in some Mixed Modalities Training competition (at least at local level); do not present osteomyoarticular injury that prevent the WOD from being performed; do not present cardiomyopathy, muscular dystrophy, neurological disease; do not present pain in the lower limbs; do not have hypersensitivity or ice allergy; do not have Raynaud syndrome; be in the period immediately after menstruation, in the follicular phase of the menstrual cycle (only for female participants)

Exclusion criteria

Exclusion criteria: Could not complete the exercise protocol in the assessment; do not complete any of the study procedures for any reason; make use of energy drinks, anabolic steroids, drugs, among other substances that can increase performance during the assessment period; make use of analgesic, anti-inflammatory or central nervous system depressants during the research.

Design outcomes

Primary

MeasureTime frame
Delayed onset muscular soreness will be main outcome of the study and will be assessed through the Analogue Visual Scale. We will observe the pain level during the three days of assessment and our hypothesis is that the experimental group would show lower rates of pain;Muscle strength or peak torque will also be considered as main outcome. We will observe their behavior before and after training and after intervention. For this purpose, an isokinetic dynamometer will be used to verify peak torque of knee extensors. The experimental groups are expected to return to baseline levels more rapidly when compared to control groups.

Secondary

MeasureTime frame
The presentation for funtional performance will be made through evaluation of triple hop test, where the individual will perform before and after training and after intervention. Our hypothesis is that participants from the experimental groups return to baseline values more quickly qhen compared to control groups.;There will be presentation of Creatine Kinase (CK) levels to analyze muscle damage generated by the proposed exercise

Countries

Brazil

Contacts

Public ContactWouber ;Wouber Vieira;Vieira

Universidade Federal do Rio Grande do Norte;Universidade Federal do Rio Grande do Norte

hericksonfisio@yahoo.com.br;hericksonfisio@yahoo.com.br55 84 32154270;32154270

Outcome results

None listed

Source: REBEC (via WHO ICTRP)